BUILDING THE
NEW PILLARS OF GROWTH

At Metropolis, precision, technological adeptness and proficiency form an important component of our operations. Our growth strategy envisions establishing Metropolis as a customers’ first choice. Since our inception, the business’ emphasis remained on providing accurate test results for gaining trust and confidence of our customers in healthcare.

Backed by strong scientific capabilities and tech savviness, we strive to ensure access to advanced high-quality diagnostic testing to patients not only in metro cities but also in tier 2 and tier 3 cities. To realize our goal, we are pursuing network expansion for deeper market penetration, prudent investments in digitization for better services and smoother customer experience, extending home visit coverage to make Metropolis the ‘Go-To’ brand for home testing.

Metropolis is becoming more self-reliant as it continues to ensure world-class pathology services for its customers, driven by advanced quality diagnostics, timely diagnosis without compromising quality, alongside deeper industry insight. Thereon, unlocking the next level of growth with ‘Metropolis 3.0’ and BUILDING THE NEW PILLARS OF GROWTH.

about us

METROPOLIS:
Fundamentals of Our Growth

vision

To be a respected healthcare brand trusted by clinicians, patients and stakeholders. Positively impact lives of patients in their most anxious times and turn their anxiety into assurance.


Mission Statement

Helping people stay healthy, by accurately revealing their inner health.


value

integrity
is in our
veins
empathy
is in our
blood
accuracy
is in our
dna
read more

We are certified

Mumbai lab is CAP accredited since 2005
NABL accreditation
More than 75% reports are generated by accredited labs
NABL accreditation follows ISO-15189 standard and is recognized by ILAC & APLAC
*CAP: College of American Pathologists *NABL: National Accreditation Board for Testing and Calibration Laboratories.
  • tests
    26mn
  • CUSTOMER/PATIENT
    VISITS IN 2021-22
    13.4mn
  • NABL-ACCREDITED
    Labs
    25
  • Pick-up Points
    ~ 9,000
  • Assisted Referral
    Centers (ARC)
    704
  • Years of Credible
    Operations
    40+
  • Patient Service
    Centers
    3,134
  • Clinical
    Laboratories
    171
  • Tests and Profiles
    4,000+
  • Presence Across
    Indian States
    20
  • Patients
    Touchpoints
    12,000+
  • Presence across
    Indian Cities
    220

Message from
Chairman’s Desk

We are becoming a self-reliant world-class pathology services provider driven by robust R&D, technological capabilities, and industry experience.

read more

Letter from the
Managing Director

We are enhancing diagnostic value with innovative testing to bring greater trust and confidence to healthcare. And by co-creating new values with our stakeholders, we strive to contribute to the development of healthcare and the healthy lives of people.

read more

Our Value Creation Process

Leading Our Growth Endeavours

Financial Capital

We primarily use debt and equity raised from our investors and creditors.

Service Capital

We leverage our service network labs and state-of-the-art laboratories for achieving the ultimate results.

Intellectual Capital

Our digital ecosystem, along with the knowledge-based tangible assets, blended with our ethics, help us deliver effective customer service.

Human capital

We train and nurture the skills and experiences of our employees to conduct test carefully and accurately.

Social and Relationship Capital

Our relationship with our societies, customers, partners, associated doctors, and Government enables us to address their needs for them.

Natural Capital

We believe in playing an effective role of good global citizen by reducing our environmental footprint through various initiatives.

Vision
Mission
Values
Focus areas
  • Organic and inorganic are the cornerstones that will propel growth, in the way forward
  • Aggressive network expansion to establish better connection with our customers
  • Creating easier and more engaging interaction with our customers
  • Productivity of existing young network
Risk and Opportunities
  • Regulatory
  • Competition
Financial Capital
  • Revenue from Operations amounted to INR 1,228 Crores
  • Turnover increased by 23%
  • EBITDA increased by 21%
  • PAT increased by 17%
Service Capital
  • More than 4000% tests & profiles
  • 26mn tests & 13.4mn patient visits in FY 2021-22
  • Over 12000 patient touchpoints
Intellectual Capital
  • Created digital ecosystem for all stakeholders
  • Click<>Brick: Created seamless omni-channel experience
  • Enhanced patient experience with an automated multi-model experience (Web, Mobile App, WhatsApp, Chat)
Human capital
  • With over 60% of the workforce belonging to the millennial generation, the team is young, enthusiastic, and motivated
  • 4500 highly skilled and motivated employees
  • Workplace equality and a strong work culture
Social and Relationship Capital
  • We have been at the forefront of organizing impactful camps and leading numerous workshops for various segments of society
  • To make a difference in the lives of those we touch, we collaborate with societies, corporate groups, educational institutions, Government bodies, NGOs, wellness foundations, and a variety of other organizations
  • We have identified four distinct areas to contribute and truly make a difference through well-designed programs
Natural Capital
  • LED lights have replaced with the traditional lights in all of our corporate offices and labs to save energy
  • Our largest lab (The Global Reference Lab in Mumbai) has a sewage water plant, and treated water is used for toilet flushing and gardening
  • Being a responsible entity in the healthcare fraternity, we take great effort to ensure the safe disposal of biomedical waste through Pollution Control Board-approved agency
  • Our EHS policies and its standard operating procedures, apply to the Company and its subsidiaries
Shareholders

We aim to deliver consistent, competitive, profitable and responsible growth.

Our people

We aim to reward people fairly for the work they do, while helping them find their purpose, to bring out the best in them.

Customers

We aim to provide accurate test results along with best-in-class home visit service.

Our Partners

We establish strategic partnership with Third-Party Patient Service Centers in India, Africa and Middle East, expanding our geographic reach.

Government

We provide best-in-class service to the Government contracts we receive.

Society

We believe in making healthier planet while contributing to a fairer and more socially inclusive world.

Input

Financial Capital

We primarily use debt and equity raised from our investors and creditors.

Service Capital

We leverage our service network labs and state-of-the-art laboratories for achieving the ultimate results.

Intellectual Capital

Our digital ecosystem, along with the knowledge-based tangible assets, blended with our ethics, help us deliver effective customer service.

Human capital

We train and nurture the skills and experiences of our employees to conduct test carefully and accurately.

Social and Relationship Capital

Our relationship with our societies, customers, partners, associated doctors, and Government enables us to address their needs for them.

Natural Capital

We believe in playing an effective role of good global citizen by reducing our environmental footprint through various initiatives.

Output

The Value We Create For

Shareholders

We aim to deliver consistent, competitive, profitable and responsible growth.

Our people

We aim to reward people fairly for the work they do, while helping them find their purpose, to bring out the best in them.

Customers

We aim to provide accurate test results along with best-in-class home visit service.

Our Partners

We establish strategic partnership with Third-Party Patient Service Centers in India, Africa and Middle East, expanding our geographic reach.

Government

We provide best-in-class service to the Government contracts we receive.

Society

We believe in making healthier planet while contributing to a fairer and more socially inclusive world.

At Metropolis, our financial capital testifies for our view and prudence in ensuring optimal resource allocation and control systems to drive the business’ operations. Our strategic investments further strengthen our business’ growth momentum overall performance. The following is a snapshot of the Company’s Revenue, EBITDA, PAT along with Revenue per Test and Revenue per customer, as recorded during the year under review.

read more

At Metropolis, our customer-centric approach and world-class quality services led us to establish a loyal and expansive customer base. We provide access to conclusive diagnosis and full test profiles, backed by a robust digital connect, cutting-edge technology, and accurate diagnostic results. We are constantly finding newer ways to grow our network footprint across our region of operation, while striving to serve better with evolving times.

read more

At Metropolis, we are committed towards providing customer-focused services with convenience and accuracy. We constantly endeavour towards effectively upgrading our knowledge and skills. Moving ahead, we focus on driving enhanced patient experience via creating digital ecosystem along with improved service levels at optimal costs while driving better results.

Our Intellectual capital lays on emphasis on conducting robust research and development to introduce newer specialized tests for providing better customer value. Backed by our team of proficient scientists and doctors, we focus on enhancing and bringing new developments in pathology globally. Our continuous investment towards intellectual capital facilitates us to stay ahead, while focusing on highest standards of quality.

read more

At Metropolis, we lay a special emphasis on social issues, also reflected in our way of doing business. We embrace and respect the cultural diversity in our team that comprises of employees led by their strong sense of conviction. They play a significant role as our key management resource and provide support to our strategic growth. As we march ahead in alignment to the Company’s vision, we reflect oneness, inclusiveness and high team spirit to endure the subsequent challenges.

read more

Our Social and Relationship capital represents the shared values, the willingness to engage and the intangibles associated with Metropolis brand recall. We are a socially responsible entity and committed to serve the nation’s cause, states, and the local communities.

read more

Financial Capital
Numbers testifying our growth potential

At Metropolis, our financial capital testifies for our view and prudence in ensuring optimal resource allocation and control systems to drive the business’ operations. Our strategic investments further strengthen our business’ growth momentum overall performance. The following is a snapshot of the Company’s Revenue, EBITDA, PAT along with Revenue per Test and Revenue per customer, as recorded during the year under review.

read more

Service Capital
Growth-oriented, customer-centric approach

At Metropolis, our customer-centric approach and world-class quality services led us to establish a loyal and expansive customer base. We provide access to conclusive diagnosis and full test profiles, backed by a robust digital connect, cutting-edge technology, and accurate diagnostic results. We are constantly finding newer ways to grow our network footprint across our region of operation, while striving to serve better with evolving times.

read more

Intellectual Capital
Enhancing Adeptness to Drive Progress

At Metropolis, we are committed towards providing customer-focused services with convenience and accuracy. We constantly endeavour towards effectively upgrading our knowledge and skills. Moving ahead, we focus on driving enhanced patient experience via creating digital ecosystem along with improved service levels at optimal costs while driving better results.

read more

Human Capital
Building Team Spirit for Achieving Growth

At Metropolis, we lay a special emphasis on social issues, also reflected in our way of doing business. We embrace and respect the cultural diversity in our team that comprises of employees led by their strong sense of conviction. They play a significant role as our key management resource and provide support to our strategic growth. As we march ahead in alignment to the Company’s vision, we reflect oneness, inclusiveness and high team spirit to endure the subsequent challenges.

read more

Social and Relationship Capital
Achieving Holistic Growth

Our Social and Relationship capital represents the shared values, the willingness to engage and the intangibles associated with Metropolis brand recall. We are a socially responsible entity and committed to serve the nation’s cause, states, and the local communities.

read more

Dr. Sushil Kanubhai Shah

Designation: Chairman & Executive Director

Qualification: Bachelor’s Degree in Medicine and Surgery and Ph.D Medicine in Pathology and Bacteriology from University of Bombay.

Exprience: More than four decades of experience in Pathology business


Mr. Sushil Shah is the Founder of the Company and has been a Director on our Board since 2005. He was awarded the Maharashtra Gaurav Award by the Government of India and the Lifetime Achievement Award at the Six Sigma Healthcare Excellence Awards. He was also awarded the Rajiv Gandhi Excellence Award by the Indian Solidarity Council and the Rashtriya Chikitsak Ratna Award by the National Education & Human Development Organization.

Ms. Ameera Sushil Shah

Designation: Promoter & Managing Director

Qualification: A Degree in Finance from The University of Texas at Austin and the prestigious Owner-President Management (OPM) Program at Harvard Business School.

Exprience: More than two decades of experience in Pathology business


Ms. Ameera Sushil Shah has been a Director on our board since 2008. A global thought leader in the Healthcare industry, she has played an instrumental role in changing the Pathology industry landscape in the country; from being a doctor led practice to a professional corporate group in an extremely unregulated, competitive, and fragmented market.
Over the two decades, Ms. Shah has built the organization across the board, and has been a dynamic driving force behind the entire corporate transformation and the sustained growth of Metropolis. Due to its unique growth model and competitive advantage, Metropolis has attracted three rounds of investment by reputed private equity investors. Under the leadership of Ms. Shah, Metropolis was successfully listed at the stock exchanges in 2019 and within three years of its listing, we cemented a position of trust with international and domestic investors by posting industry leading performance every quarter and delivering good returns on their investments. Upholding the highest standards of corporate governance and business ethics, Metropolis has built exceptional value for all our stakeholders.
Ms. Ameera Shah is the recipient of the Entrepreneur of the Year Award in healthcare category for the year 2021 from Ernst & Young. Ms. Shah is one of the three women to ever receive this award in the past 20 years and the youngest woman ever to receive this award. She has been named amongst ‘Asia’s Power Businesswoman’ (2020) by Forbes Asia, ‘Fifty Most Powerful Women in Business’ by Fortune India (2017, 2018, 2019, 2020, 2021) and Business Today (2018, 2019, 2021). She has been bestowed with multiple awards for her outstanding performance & excellence in diagnostics business and entrepreneurship from various reputed organizations.
Ms. Ameera Shah is an eminent industry spokesperson and has been a speaker in various National and International forums, industry events and conclaves. She has been an active member & has served senior level positions in key industry bodies that drives policy decisions at the Center. She is currently serving as a Vice-President of NATHealth (Healthcare Federation of India).
Ms. Shah was an Independent Director for Marico, Kaya in the past and is currently on the board for reputed Indian companies such as Torrent Pharma, Shoppers Stop. She is also an Advisor to Baylor College of Medicine, Texas. She is also on the global Advisory Board of AXA, a Paris headquartered company with USD 700 bn asset under management.

Mr. Vivek Gambhir

Designation: Non Executive Independent Director

Qualification: Bachelor’s degree in both Science and Arts from Lafayette College, Pennsylvania; Holds Master’s degree in Business Administration from Harvard University.

Exprience: More than ten years of experience in Operations and Strategy


Vivek Gambhir is currently associated with Imagine Marketing India Private Limited (BoAt Lifestyle) as the Chief Executive Officer. Prior to joining BoAt Lifestyle, he worked with Godrej Consumer Products Limited & its associate companies. He was also a founding member of Bain’s consulting operations in India and led the firm’s FMCG practice in India. He has been a Director on our Board since September 2018.

Mr. Sanjay Bhatnagar

Designation: Non Executive Independent Director

Qualification: Master’s degree in Engineering from Stanford University and Business Administration from Harvard University.

Exprience: More than 16 years of experience in project development, marketing, and operations management


Sanjay Bhatnagar has served as the Chairman of the American Chamber of Commerce in India and as a Board member of the US India Strategic Partnership Forum. Prior to joining the Company, he has worked with Enron India Private Limited, WaterHealth International Inc. and the THOT Capital Group LLC. He has been a Director on our Board since 2018.

Mr. Milind Sarwate

Designation: Non Executive Independent Director

Qualification: Chartered Accountant, Cost Accountant, Company Secretary and a CII-Fulbright Fellow (Carnegie Mellon University, USA)

Exprience: 31 years of executive experience with long stints as CFO, CHRO (Marico & Godrej). 16 years of non-executive directorships on listed company boards.

Awarded ICAI CFO Award (2011), CNBC TV-18 CFO Award (2012) & CFO India Hall of Fame induction (2013)


Mr. Milind Sarwate is the Founder & CEO of Increate (https://increate.in/). He provides advice and mentorship in business and social value creation, governance, and capability-building. Mr. Sarwate has been a Director of the Company since 2018. He has been serving as an Independent Director in both listed and unlisted companies, with a focus on audit committee roles. He is currently on the Board of companies such as Asian Paints, Mahindra Finance, Nykaa, Hexaware, OmniActive Health, and Eternis. His previous Board memberships include Mindtree, International Paper, House of Anita Dongre, and CARE Ratings. Besides Directorships, he is also an Advisor, Mentor and ESG Contributor.
He invests in promising businesses and social enterprises and recently set up a not- for-profit Company, Increate Foundation. He is currently an Advisory Board Member for a School Support NGO – Educo.

Ms. Anita Ramachandran

Designation: Non Executive Independent Director

Qualification: MBA (Finance) from the Jamnalal Bajaj Institute

Exprience: More than 40 years of experience as a Management Consultant


Anita Ramachandran began her career in the Management Consultancy division of AF Ferguson & Co (the KPMG network company in India then) in Mumbai in 1976 as the first woman consultant in the firm and worked in a wide range of areas from finance, industrial market research, strategy, and human resources consulting. She founded M/s. Cerebrus Consultants in the year 1995 to focus on HR advisory services, which has now established itself as a specialist firm in the HR field. Anita has worked with over 350 companies in South Asia on a range of HR issues. Her wide general management consulting experience and insights on HR has enabled her to be a strategic advisor to many family groups. She supports many organizations in the social sector through pro bono professional work and remains deeply committed to working with women.

Mr. Hemant Sachdev

Designation: Non Executive Director

Qualification: BA (Political Science) from Delhi; An alumni of Harvard Business School

Exprience: More than 20 years of experience


Mr. Hemant Sachdev is a BA in Political Science from Delhi and an alumni of Harvard Business School. He is a first generation entrepreneur and has over 2 decades of experience. He has his business interests in Retail, Distribution and Education.

read more

Dr. Sushil Kanubhai Shah

Chairman and Executive Director

Ms. Ameera Sushil Shah

Managing Director

Mr. Vijender Singh

Chief Executive Officer

Dr. Nilesh Jadavji Shah

Group President and Chief of Science and Innovation

Mr. Rakesh Agarwal

Chief Financial Officer

Ms. Ishita Medhekar

Chief Human Resource Officer

Mr. Kannan Alangadan

Chief Operating Officer – Operations, Healthtech Business and Services

Mr. Sriram Iyer

Chief Revenue Officer

Dr. Kirti Chadha

Chief Scientific Officer

read more